🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 590717104
- Market Cap
- Small Cap
- ADR Ratio
- 1:5
Business: Mesoblast Ltd. is using its proprietary technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex diseases resistant to conventional standard of care and where inflammation plays a central role.
Company Contact
- CEO
- Silviu Itescu
- CFO
- James M. O’Brien
- Headquarters
- 505 Fifth Avenue, Level 3, New York, NY 10017
- Phone
- 212-880-2060
- Fax
- 212-880-2061
- Investor Relations
- Schond Greenway · 212-880-2060 · investors@mesoblast.com